Promising Mpox Drug Fails in Trials as Virus Spreads
As mpox continues to spread in Central Africa, a promising antiviral drug to treat the infection has failed to improve patients’ symptoms in a trial in the Democratic Republic of the Congo, the epicenter of the outbreak. In the trial, the drug tecovirimat, also known as TPOXX, did not alleviate the characteristic blisterlike rash seen … Read more